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Abstract 
Background: Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality globally. Primary 
prevention of CVD based on total CVD risk approach using WHO/ISH risk prediction chart would be more effective 
to stratify population under different risk levels, prioritize and utilize the scarce resources of low and middle-income 
countries. This study estimated total 10-year CVD risk and determined the proportion of population who need imme-
diate drug therapy among the rural population of Nepal.
Methods: A community based cross-sectional study conducted among 345 participants aged 40–80 years in rural 
villages of Lamjung District of Nepal. They were selected randomly from total eighteen wards. Data were collected 
using WHO STEPS questionnaires. WHO/ISH risk prediction chart for SEAR D was used to estimate total cardiovascular 
risk. Chi-square and independent t-test were used to test significance at the level of p < 0.05 in SPSS version 16.0.
Results: Of the total participants, 55.4% were female. The mean age (standard deviation) of the participants was 
53.5 ± 10.1 years. According to WHO/ISH chart proportions of low, moderate and high CVD risk were 86.4%, 9.3%, and 
4.3%, respectively. Eleven percent of participants were in need of immediate pharmacotherapy. Age (p = 0.001), level 
of education (p = 0.01) and occupation (p = 0.001) were significantly associated with elevated CVD risk.
Conclusion: A large proportion of Nepalese rural population is at moderate and high CVD risk. Immediate pharma-
cological interventions are warranted for at least one in every ten individuals along with lifestyle interventions. Both 
population-wise and high-risk approaches are required to minimize CVD burden in the future.
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Background
Cardiovascular diseases (CVD) are the major public 
health problem globally with disproportionately higher 
occurrence and consequences in developing countries. 
Data of 2012 showed estimated deaths due to CVD 
was 17.5 million (31% of total death) with 37% of pre-
mature deaths below the  age of 70, globally. Almost 
80% of such death occurred in low and middle-income 
countries (LMIC) with the  high disparity of premature 
deaths among such LMIC [1]. In another way, it has been 
projected that 23.3 million people would die by 2030 only 
due to CVD [2]. Even in South–East Asia Region (SEAR), 
CVD accounted for a quarter (25%) of all deaths due to 
Noncommunicable Diseases (NCD) [3]. Likewise, in 
Nepal, the prevalence of CVD was 40% among all NCD 
in-patients in non-specialty hospitals [4].
Population-wise strategies and high-risk strategies are 
two important methods for prevention of CVD comple-
menting each other [5]. The high-risk strategy identi-
fies individuals who need immediate and sustained care 
to prevent the development of CVD [5]. The high-risk 
strategy can be applied through two distinct approaches, 
first one is targeting and managing each of the single risk 
factors like hypertension, hyper-cholesterol separately. 
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Another is accounting the total risk of CVD by measur-
ing the cumulative effect of relative risk of all risk factors 
[6]. However, later one seems to be accurate for identify-
ing a high-risk individual and can enable to guide limited 
healthcare resources of LMIC cost-effectively [7–9].
Established tools to estimate the total CVD risk are 
Framingham, SCORE, QRISK, ASSIGN. These tools were 
developed considering the specific population and might 
not be applicable to others [10–15]. However, World 
Health Organization/International Society of Hyperten-
sion (WHO/ISH) risk prediction charts have been devel-
oped using information on the population distribution 
of risk factors from WHO Comparative Risk Assess-
ment study of different sub-regions focusing non western 
developing countries [16, 17]. The chart estimates the 
total risk of developing fatal and non-fatal cardiovascular 
diseases (coronary artery disease and stroke) in follow-
ing 10  years among those people whose CVD were not 
manifested clinically, categorizes an individual in differ-
ent risk groups so that the person can be managed only 
by lifestyle modification or need drug therapy also [16]. 
The chart is easy to utilize by all physicians and other 
health workers at all levels of health care. This tool not 
only helps to make a clinical decision but also estimates 
and monitor population distribution of total CVD risk 
[16, 18]. However, there is paucity of evidence on the use 
of WHO/ISH risk prediction chart in Nepal. Therefore, 
this study aimed to estimate total 10-year CVD risk and 
to  determine the proportion of population who need 
immediate drug therapy among the  rural community of 
Nepal using WHO/ISH chart.
Methods
Study design and settings
This was a community-based cross-sectional study con-
ducted at Bhotewodar and Sunderbazar Village Develop-
ment Committee (VDC) of Lamjung between October 
and November 2014. These villages are about 200  km 
west from capital city Kathmandu of Nepal and consist of 
14,275 population living in 3,869 households. These are 
the hilly rural areas where agriculture is the main source 
of livelihood. The sites are the inhabitants of culturally 
rich people like Gurung, Tamang, Magar, Newar and 
Dalit, most of them are socially deprived [19].
All eligible men and women were included as the study 
population. Eligible criteria were age 40–80 years, with-
out having self-reported angina, myocardial infarction, 
stroke,  and intermittent claudication. Pregnant women, 
mentally retarded and bed-ridden patients were excluded 
from the study.
Sample size and sampling technique
The sample size was calculated by using the formula for 
estimation of proportion for one sample situation. To 
detect prevalence of 9.5% of moderate and high CVD risk 
population, as determined by a study conducted in sub-
urban municipalities of Nepal [20], the  minimum sam-
ple size required was 292 with allowable error of 4% and 
a  design effect of 1.5. Taking into consideration a non-
response rate of 15%, we decided to select 343 subjects 
from all male and female population aged 40–80  years 
(N = 3712).
A cluster sampling technique was used to recruit 
the required number of participants for the study. Firstly, 
four wards were selected out of 18 wards using probabil-
ity proportion to size (PPS). In each ward, we selected 
the first household from a randomly selected point at the 
entry of the main road. Then, every 6th household was 
taken as the  study household. All eligible members of 
each household were listed and one subject was selected 
randomly for interview by using Kish Table [21].
Data collection
Five health professionals who had at least intermediate 
level of health-related education were trained for one 
week on study protocol, tools and data collection tech-
niques of the study. Data were collected using stand-
ard STEPS instrument version 2.2 [21]. The survey tool 
encompassed questions related to demography and 
socio-economy, tobacco and alcohol use, dietary intake, 
physical activity level, and history of high blood pressure 
and diabetes. The questionnaires were translated into 
Nepali language and revised after conducting a pilot sur-
vey among 20 participants. Blood pressure was measured 
using doctor’s aneroid sphygmomanometer and stetho-
scope with an appropriately sized cuff on the unclothed 
left arm. First reading was taken after 15 min rest-cross-
ing leg and second and third readings were recorded at 
5 min interval. Trained technical person collected venous 
blood, after conforming overnight 12 h fasting to meas-
ure blood sugar and lipid profile. All biochemical meas-
urements were done using semi-automated machine of 
Erba Mannheim (Germany), chem5 v3 model.
WHO/ISH risk prediction chart
WHO/ISH chart for SEAR D of WHO epidemiological 
sub-region [22] was used to estimate the total 10-year risk 
of CVD of all participants. Age, gender, smoking status, 
systolic blood pressure, presence or absence of diabetes 
and total serum cholesterol in millimole/liter (mmol/l) 
were used to compute the total CVD risk. The chart can 
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stratify an individual into low (<10%), moderate (10% to 
<20%), high (20% to <30%), and very high (>30%) risk 
groups [16].
Definitions of variables
A smoker was the one who has smoked currently and 
who quit smoking less than one year before the assess-
ment [23]. Systolic blood pressure was mean of last 
two readings. A respondent with diabetes mellitus was 
defined as the one  who had fasting venous blood sugar 
level 7  mmol/l or who was taking oral hypoglycemic 
drug or insulin [23, 24]. Caste was categorized into upper 
caste (Bramhan and Kshetri), Janajati (Gurung, Tamang, 
Newar, Magar and Thakali) and Dalit (low caste). For 
occupation, respondent working in paid governmen-
tal and nongovernmental organization was  labeled as 
employed, running own business as self-employed, and 
student or housemaker or non-paid worker as unem-
ployed. Economic status was categorized as poor (<8498) 
and medium to high (≥8498) economic status accord-
ing to family income per person per month in Nepalese 
Rupees (NR) [25].
Statistical analysis
Data were compiled and entered in Epidata version 3.1. 
Duplication and omissions of data were checked and 
edited before coding and exporting into SPSS V.16.0 
for further analysis. Descriptive statistics were  used to 
compute different risk categories with 95% confidence 
interval (CI) for proportion. Mean was calculated with 
standard deviation (SD) for continuous variables. Chi-
square and independent t-tests were conducted to com-
pare categorical and continuous variables, respectively. 
All tests were two-tail test and p < 0.05 was considered 
statistically significant.
Ethical consideration
Ethical clearance was obtained from ethical review 
committee of Nepal Health Research Council. Writ-
ten informed consent or thumb impression (if unable 
to write) were taken from all participants. Study objec-
tives, data collection procedures, benefits and risks of 
the  study, confidentiality, and anticipated use of the 




Total 345 participants were attended in the study. Mean 
age of study participants was 53.5  ±  10.1  years. The 
majority of participants were female (55.4%). Forty per-
cent of respondents were in the lowest age group of 
40–49 years. Almost all study participants were married 
(91.3%). More than half of participants (53.6%) did not 
have formal education. The majority of participants were 
janajati (55.4%), unemployed (58%). Almost all partici-
pants (91.5%) had poor economic status (Table 1).
Total 10‑year CVD risk using WHO/ISH chart
The majority of people had low (<10%) 10-year CVD risk 
[86.4% (CI 82.8–90)]. Moderate and high risk were 9.3% 
(CI 6.2–12.4) and 4.3% (CI 2.2–6.4), respectively. More 
female (10.5%) than male (7.8%) had moderate risk. How-
ever, more men (4.5%) than women (4.2%) were at high 
CVD risk (Table  2). Of total study participants, 6 (1.7%) 
were at >30% CVD risk (Table 3). As expected, total CVD 
risk was increasing with age. The highest risk was observed 
among 70–79  years where almost 44% were at moderate 
risk and 15.6% were at high risk. While only 0.7% were at 
moderate and high risk at the age of forties (Table 2). 
Table 1 Socio-demographic characteristics of respondents
Chi square test was done
* Is significant
a Fischer-exact test
b Independent t test for mean difference
Characteristics Male, n (%) Female, n (%) Total, n (%) p value
Age in years
 40–49 65 (42.2) 72 (37.7) 137 (39.7) 0.6
 50–59 46 (29.9) 59 (30.9) 105 (30.4)
 60–69 32 (20.8) 39 (20.4) 71 (20.6)
 70–79 11 (7.1) 21 (11) 32 (9.3)
 Mean ± SDb 53.3 ± 9.9 53.7 ± 10.3 53.5 ± 10.1 0.68
Marital statusa
 Married 152 (98.7) 163 (98.3) 315 (91.3) 0.001*
 Widow or wid-
ower
2 (1.2) 28 (14.6) 30 (8.6)
Level of educationa
 No formal edu-
cation
30 (19.5) 155 (81.2) 185 (53.6) 0.001*
 Primary school 49 (31.1) 21 (11) 70 (20.3)
 ≥Secondary 
school
75 (48.7) 15 (7.9) 90 (26.1)
Caste
 Upper caste 67 (43.5) 66 (34.6) 133 (38.6) 0.03*
 Janajati 74 (48.1) 117 (61.3) 191 (55.4)
 Dalit 13 (8.4) 8 (4.2) 21 (6.1)
Occupationa
 Employed 33 (21.4) 7 (3.7) 40 (11.6) 0.001*
 Self-employed 54 (35.1) 24 (12.6) 78 (22.6)
 Unemployed 42 (27.3) 158 (82.7) 200 (58)
 Retired 25 (16.2) 2 (1) 27 (7.8)
Economic status
 Poor 135 (39.2) 179 (52.3) 314 (91.5) 0.05*
 Medium and 
high
19 (12.3) 12 (6.3) 31 (9.0)
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Socio‑demographic factors associated with elevated 
10‑year CVD risk
CVD risk was significantly (p  =  0.01) associated with 
the  level of education. Of participants without formal 
education, 18.4% had elevated CVD risk. However, it was 
10% and 6.7% of participants who had a primary and sec-
ondary level of education. Elevated CVD risk was higher 
among Janajati and Dalit (14.7% and 14.3%) in com-
parison to upper caste participants (12%). Participants 
whose partner was not alive (30%) had higher CVD risk 
compared to married (12.1%). Occupation was signifi-
cantly (p = 0.001) associated with CVD risk. Of students, 
homemaker or non-paid workers, 16% had elevated CVD 
risk. Similarly, among retired participants, 37% had more 
than 10% CVD risk. However, the elevated risk was only 
1.3% and 10% among self-employed and employed par-
ticipants, respectively (Table 3).
Proportion of population who need immediate drug 
therapy
The estimated proportion of population who need drug 
therapy was 8.6% using threshold of >30% risk and while 
it was 11% at threshold level of >20% risk. However, such 
estimated proportion was more than threefold (36%) 
using single risk factor approach. Proportion of men 
who required drug intervention was 11.7% and 14.3% 
at threshold of >30% and >20% CVD risk, respectively. 
While proportion of women was 6.3% and 8.4% at same 
threshold level (Table 4).
Discussion
Our study had an objective to estimate total 10-year 
CVD risk among study population. This study found 
that large proportion of study participants had moderate 
to high risk (13.6%) which was consistent with the find-
ings reported in national and international studies con-
ducted in similar settings. This proportion of population 
at elevated risk of CVD was almost same in one sample of 
Nepal (13.4%) reported by Mendis et al. [7], while higher 
than the finding of another study conducted in a  sub-
urban population of Nepal (9.5%) [20]. However, the pro-
portion of raised risk in current study was slightly lower 
than that of Kathmandu (14.6%) [26] and rural India 
(16%) [27]. Regarding the proportion of population under 
high risk of CVD, it was slightly higher in our study 
Table 2 Distribution of study population into low, moder-
ate and high cardiovascular risk categories, n (%)
Sex Age (years) Risk categories
Low risk Moderate risk High risk
Male 40–49 64 (98.5) 1 (1.5) 0 (0.0)
50–59 43 (93.5) 2 (4.3) 1 (2.2)
60–69 24 (75.0) 4 (12.5) 4 (12.5)
70–79 4 (36.4) 5 (45.5) 2 (18.2)
Total 135 (87.7) 12 (7.8) 7 (4.5)
Female 40–49 71 (98.6) 0 (0) 1 (1.4)
50–59 56 (94.9) 2 (3.4) 1 (1.7)
60–69 27 (69.2) 9 (23.1) 3 (7.7)
70–79 9 (42.9) 9 (42.9) 3 (14.3)
Total 163 (85.3) 20 (10.5) 8 (4.2)
Male and Female 40–49 135 (98.5) 1 (0.7) 1 (0.7)
50–59 99 (94.3) 4 (3.8) 2 (1.9)
60–69 51 (71.8) 13 (18.3) 7 (9.9)
70–79 13 (40.6) 14 (43.8) 5 (15.6)
Total 298 (86.4) 32 (9.3) 15 (4.3)
Table 3 Socio-demographic factors associated with  ele-
vated 10-year CVD risk, n (%)
Chi square test was done
* Is significant
a Fischer exact test




 Male 135 (87.7) 19 (12.3) 0.53
 Female 163 (85.3) 28 (14.7)
Age
 40–49 135 (98.5) 2 (1.5) 0.001*
 50–59 99 (94.3) 6 (5.7)
 60–69 51 (71.8) 19 (59.4)
 70–79 13 (40.6) 19 (59.4)
Level of education
 No formal education 151 (81.6) 34 (18.4) 0.01*
 Primary 63 (90.0) 7 (10.0)
 ≥Secondary 84 (93.3) 6 (6.7)
Caste/ethnicity
 Upper cast 117 (88.0) 16 (12.0) 0.46
 Janajati 163 (85.3) 28 (14.7)
 Dalit 18 (85.7) 3 (14.3)
Marital status
 Married 277 (87.9) 38 (12.1) 0.006*
 Widow or widower 21 (70.0) 9 (30.0)
Occupationa
 Employ 36 (90.0) 4 (10.0) 0.001*
 Self employed 77 (98.7) 1 (1.3)
 Unemployed 168 (84.0) 32 (16.0)
 Retired 17 (63.0) 10 (37.0)
Economic status
 Poor (≤NRs 8498) 271 (86.3) 43 (13.7) 0.9
 Higher (>NRs 8498) 27 (87.1) 4 (12.9)
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(4.3%) than that of study conducted in Malaysia (2.3%) 
and Cambodia (1.3%) and lower than that of Mango-
lian study (6%) [12]. Similar heterogeneous results were 
observed in different countries (China 1.1%, Iran 1.7%, 
Sri Lanka 2.2%, Cuba 2.8%, Nigeria 5.0%, Georgia 9.6%, 
Pakistan 10.0%) [7]. Very high-risk (>30%) was 1.7% in 
our study, which was slightly lower than the estimated for 
age 40–65 years throughout the country of Nepal (3.2%) 
[28]. These different data revealed that the population 
under risk for development of stroke and coronary heart 
disease were high even in a  rural community of Nepal. 
Application of WHO/ISH chart helps to categorize popu-
lation into different risk levels. Population-based lifestyle 
modification strategy can be applied to low-risk popula-
tion while individual counseling and frequent follow-up 
assessment need to be added for moderate risk popula-
tion. However, more rigorous treatment strategies would 
be needed for the population at high and very high-risk 
category [16].
CVD risk was significantly associated with the  level 
of education. A study conducted in Vienna echoed the 
same finding that education is associated with the level 
of understanding on risk factors [29]. Evidence also sug-
gests that increasing knowledge on risk factors can sub-
stantially motivate people for changing risk behaviors 
[30]. This fact suggests that we need to improve aware-
ness and knowledge about prevention of cardiovascular 
diseases. Occupation was significantly associated with 
elevated CVD risk. A higher proportion of unemployed 
and retired participants had raised risk. One study of 
Mauritius also proved the association of occupation and 
cardiovascular risk, mostly related to physical activities 
and economic status [31]. These findings provide the evi-
dence that we should target unemployed population for 
early prevention of cardiovascular disease. As expected, 
age-related increase in CVD risk was associated with 
an increase in risk factor level [32].
As explained in the WHO guideline for assessment and 
management of cardiovascular disease [16], individu-
als who have blood pressure of ≥160/100  mm Hg need 
appropriate drug therapy even though they are in low 
and moderate CVD risk category. However, there is still 
no universal consensus for appropriate threshold (30% vs 
20%) of total CVD risk at which drug treatment are initi-
ated [7, 16]. It depends on the availability of resource of 
a country and impact of the  specific intervention. Cur-
rent data reveals that we can prevent large numbers of 
ischemic heart disease and stroke incidence if threshold 
is reduced from  >30 to >20% risk. Our result demon-
strated that about 11% would be treated by drug if >20% 
risk was taken as threshold while about 8.6% would need 
drug at threshold of  >30% risk. However, about three-
fold more individual would require pharmacotherapy if 
we target single risk factors like hypertension and raised 
cholesterol. Our estimation of proportion of the popula-
tion in need of drug therapy was slightly lower than that 
of Bangladesh at same threshold level (8.3% and 4%). 
However, as in our study, population who require drug 
were almost threefold higher by targeting single risk 
factors (28.2%) [33]. Our estimation was comparable to 
another study conducted at Cuba [34], where sample 
population requiring drug at aforementioned thresh-
old level were 12.5% and 11.5% with total risk approach 
restricting about threefold of the  population from over 
prescription of drug than single risk factor approach 
(43.8%). Similar result was found in a study in Africa [7, 
9]. Therefore, high proportion of the population were in 
need of pharmacotherapy and it would prevent over pre-
scription of the drug if total CVD risk approach applied 
to prevent CVD.
Table 4 Study population requiring pharmacotherapy using WHO/ISH chart at different threshold levels and single risk 
factors approach, n (%)
a BP ≥ 160/100 mmHg
b Chart with BP ≥ 160/100 mmHg vs single risk factor, at >30% threshold, χ2 = 64, p = 0.001
c Chart with BP ≥ 160/100 mmHg vs single risk factor, at >20% threshold, χ2 = 64.5, p = 0.001
Approach Variants Persons requiring drugs
Threshold CV risk >30% Threshold CV risk >20%
Male Female Total Male Female Total
WHO/ISH chart Chart 2 (1.3) 4 (2.0) 6 (1.8) 7 (4.5) 8 (4.2) 15 (4.3)
Chart + BPa 16 (10.6) 8 (4.2) 24 (6.9) 15 (9.7) 8 (4.2) 23 (6.6)
Total 18 (11.7) 12 (6.3) 30 (8.6)b 22 (14.3) 16 (8.4) 38 (11)c
Single risk factor BP ≥ 140/90 58 (38.7) 52 (27.2) 110 (31.9) 58 (38.7) 52 (27.2) 110 (31.9)
TC ≥ 6 8 (5.2) 6 (3.1) 14 (4.1) 8 (5.2) 6 (3.1) 14 (4.1)
Total 64 (43.9) 58 (30.3) 124 (36) 64 (43.9) 58 (30.3) 124 (36)
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Due to lack of data related to cardiovascular morbidity 
and mortality, WHO/ISH charts have not validated yet 
in Nepal. The chart might have underestimated the total 
CVD risk, as it did not include the individual with anti-
hypertensive therapy, raised triglyceride, low HDL, fam-
ily history of CVD and obesity. Higher number of janajati 
participants were involved in the study. Therefore, find-
ings of the study  should cautiously be generalized to 
other rural population of Nepal.
Conclusion
A large proportion of Nepalese rural population is at 
moderate and high CVD risk. Immediate pharmacologi-
cal interventions are warranted for at least one in every 
ten individuals along with lifestyle interventions. This sit-
uation underlines the importance of immediate designing 
and implementation of both population-wise and high-
risk approaches to minimize CVD burden in the future. 
Total risk approach would be more effective for initiation 
of preventive pharmacotherapy compared to the  single 
risk factor approach to allocate the limited resources 
more efficiently.
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